206 related articles for article (PubMed ID: 20878084)
1. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
[TBL] [Abstract][Full Text] [Related]
2. Expression of miR-22 profiling in colorectal normal-adenoma-carcinoma sequence.
Li G; Zhao D; Peng X; Zhao Y
Gene; 2024 Feb; 894():147955. PubMed ID: 37925119
[TBL] [Abstract][Full Text] [Related]
3. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
Rubie C; Frick VO; Wagner M; Schuld J; Gräber S; Brittner B; Bohle RM; Schilling MK
BMC Cancer; 2008 Jun; 8():178. PubMed ID: 18578857
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
5. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
Igder S; Mohammadiasl J; Mokarram P
Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628
[TBL] [Abstract][Full Text] [Related]
6. A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer.
Pesson M; Volant A; Uguen A; Trillet K; De La Grange P; Aubry M; Daoulas M; Robaszkiewicz M; Le Gac G; Morel A; Simon B; Corcos L
PLoS One; 2014; 9(2):e87761. PubMed ID: 24516561
[TBL] [Abstract][Full Text] [Related]
7. Role of MEK1 and DIAPH3 expression in colorectal adenoma-carcinoma sequence.
Foda AAM; El-Hawary AK; Elnaghi K; Eldehna WM; Enan ET
Tumour Biol; 2024; 46(1):1-11. PubMed ID: 38728194
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum.
Cui G; Goll R; Olsen T; Steigen SE; Husebekk A; Vonen B; Florholmen J
Cancer Immunol Immunother; 2007 Jul; 56(7):985-95. PubMed ID: 17160410
[TBL] [Abstract][Full Text] [Related]
9. Significance of p-STAT3 expression in human colorectal adenocarcinoma.
Park JK; Hong R; Kim KJ; Lee TB; Lim SC
Oncol Rep; 2008 Sep; 20(3):597-604. PubMed ID: 18695911
[TBL] [Abstract][Full Text] [Related]
10. Consensus molecular subtype classification of colorectal adenomas.
Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
[TBL] [Abstract][Full Text] [Related]
11. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
Wu D; Li Q; Song G; Lu J
J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
13. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
14. CBX2 Expression in Colorectal Mucosa-adenoma-adenocarcinoma Sequence.
Wang B; Huang M; Wang X; Tseng Y; Luo F; Liu J
J Coll Physicians Surg Pak; 2021 Sep; 31(9):1051-1056. PubMed ID: 34500520
[TBL] [Abstract][Full Text] [Related]
15. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
16. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
[TBL] [Abstract][Full Text] [Related]
17. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
[TBL] [Abstract][Full Text] [Related]
18. Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.
de Groen FL; Krijgsman O; Tijssen M; Vriend LE; Ylstra B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
Genes Chromosomes Cancer; 2014 Apr; 53(4):339-48. PubMed ID: 24478024
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
Komor MA; de Wit M; van den Berg J; Martens de Kemp SR; Delis-van Diemen PM; Bolijn AS; Tijssen M; Schelfhorst T; Piersma SR; Chiasserini D; Sanders J; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; Carvalho B; Meijer GA; Jimenez CR; Fijneman RJA;
Int J Cancer; 2020 Apr; 146(7):1979-1992. PubMed ID: 31411736
[TBL] [Abstract][Full Text] [Related]
20. IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence.
Cui G; Yuan A; Goll R; Florholmen J
Scand J Gastroenterol; 2012 Nov; 47(11):1304-12. PubMed ID: 22989213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]